Glycerin Companies

SECTION 1 — MARKET OVERVIEW

Why the Glycerin Market Is Expanding?

The global Glycerin Market is a versatile oleochemical commodity produced predominantly as a co-product of two major industrial processes: biodiesel (FAME — fatty acid methyl ester) production, where glycerol is released during the transesterification of vegetable oils or animal fats with methanol (approximately 10 kg of crude glycerin per 100 kg of biodiesel produced); and oleochemical refining (soap manufacture, fatty acid and fatty alcohol production), where glycerol is co-produced during the saponification or hydrolysis of triglyceride feedstocks. These two production routes mean that global glycerin supply is fundamentally co-dependent on the scale of the biodiesel and oleochemical industries rather than independently driven by glycerin demand — a supply structure that creates periodic price volatility when biodiesel production expands ahead of glycerin demand growth. Market Research Future projects the glycerin market growing at a steady CAGR of approximately 5.5% during the 2025–2035 forecast period, driven by pharmaceutical (USP-grade) and personal care (cosmetic-grade) demand growth that outpaces commodity technical-grade glycerin demand.

Glycerin's commercial applications span five major categories: personal care and cosmetics (35% of market value, where glycerin's outstanding hygroscopic and skin-conditioning properties make it a universal moisturizer and humectant in creams, lotions, serums, and pharmaceutical topical formulations); pharmaceuticals (USP-grade glycerin for oral liquids, topical preparations, suppositories, and injectable formulations under stringent pharmacopeia purity requirements); food and beverage (food-grade glycerin as a sweetener, humectant, solvent, and texture modifier in confectionery, bakery, and beverage applications); biofuels and energy (technical-grade glycerin as a fermentation feedstock for biogas and as a co-substrate in microbial fuel production); and industrial applications (glycerin as a solvent, antifreeze component, alkyd resin precursor, and industrial humectant). The most commercially significant structural development in the glycerin supply chain is the rapid global expansion of hydroprocessed vegetable oil (HVO/renewable diesel) capacity at the expense of FAME biodiesel growth: unlike FAME biodiesel, HVO production hydroprocesses the triglyceride backbone to propane rather than releasing glycerol, meaning each tonne of FAME replaced by HVO reduces glycerin co-production, potentially tightening glycerin supply and supporting price through 2030 as renewable diesel capacity expands under the EU's SAF mandates and US IRA incentives.

What Structurally Separates Leaders from the Field?

Leadership in the glycerin market is determined by feedstock integration, refining purity capability, and pharmaceutical-grade quality management certification infrastructure. The most fundamental structural differentiator is feedstock production scale: Wilmar, KLK OLEO, and IOI Loders Croklaan produce glycerin as an inherent co-product of palm oil refining at a production scale that makes them structural glycerin suppliers regardless of standalone glycerin market economics — their glycerin supply costs are partially subsidized by the primary oleochemical product (fatty acids, fatty alcohols) economics, enabling lower effective glycerin production costs than standalone glycerin producers. A second structural separator is pharmaceutical-grade refining and certification capability: glycerin requires sophisticated fractional distillation, activated carbon bleaching, and deodorization to achieve USP/EP pharmaceutical-grade specifications (minimum 99.5% glycerol content, <0.1 ppm heavy metals, <10 ppm residual water) alongside GMP manufacturing facility certification and batch-level certificate of analysis documentation that the relatively few producers who maintain all of these simultaneously can supply pharmaceutical customers on a sole-source or approved vendor basis. Third, the EUDR's December 2024 implementing regulations are structurally reshaping European glycerin procurement toward RSPO-certified vertically integrated Southeast Asian producers who can provide geolocation-verified deforestation-free documentation at the plantation level — a compliance infrastructure investment advantage that non-certified commodity glycerin traders cannot acquire without years of traceability system development.

SECTION 2 — TOP 10 GLOBAL GLYCERIN COMPANIES — MRFR RANKINGS (2026)

MRFR has identified and profiled the following leading glycerin companies globally, evaluated on production scale, feedstock integration, pharmaceutical-grade refining capability, EUDR compliance positioning, and strategic positioning across personal care, pharmaceutical, food, and industrial end-markets.

*Rankings based on MRFR analysis. Revenue figures are total group revenues from official filings; glycerin-specific segment revenue is not separately disclosed by any company. Most glycerin producers are diversified oleochemical or agricultural trading companies for whom glycerin is one of many co-products. Private companies are listed as Undisclosed with scale estimates where available.

SECTION 3 — DETAILED COMPANY PROFILES

1. Wilmar International Limited | SGX: F34 | Singapore

Wilmar International is the world's largest single-company glycerin producer by volume, producing glycerin as an inherent co-product of its vast palm oil refining and oleochemical processing operations at its Indonesian, Malaysian, and Chinese production complexes. With FY2024 group revenue of approximately SGD 68.4 billion (~$50.8 billion USD), Wilmar's glycerin production benefits from the world's largest integrated palm plantation-to-oleochemical refinery value chain, providing both cost advantages from scale and feedstock integration, and RSPO-certified supply chain documentation that European pharmaceutical and personal care buyers increasingly require for EUDR compliance.

2025–2026 Update: Wilmar's USD 420 million Dumai, North Sumatra expansion — commissioning mid-2026 — adds glycerin refining capacity alongside fatty alcohol and surfactant chemical capacity, expanding Wilmar's refined pharmaceutical and personal care glycerin supply for growing demand from Asian and European customers.

2. KLK OLEO (Kuala Lumpur Kepong Berhad) | Bursa: KLK | Malaysia

KLK OLEO is Malaysia's most diversified downstream oleochemical company, producing pharmaceutical-grade, food-grade, and cosmetic-grade glycerin from its palm kernel oil refining operations in Malaysia, Indonesia, the Netherlands, and Germany — with its European manufacturing sites particularly important for supplying European pharmaceutical manufacturers who require EU GMP-compliant glycerin from European-produced batches with full EU-origin quality documentation. With KLK Group FY2024 revenue of approximately MYR 26.7 billion (~$5.6 billion USD), KLK OLEO's pharmaceutical glycerin business is among the most important captive glycerin supply relationships for European pharma OEMs.

2025–2026 Update: KLK OLEO's Netherlands and Germany manufacturing sites provide the EU-origin pharmaceutical glycerin supply that European pharmaceutical companies increasingly prefer for their critical excipient supply chains following COVID-19's demonstration of single-geography dependency risks.

3. Emery Oleochemicals | Private (SD Guthrie/PTT Global Chemical JV) | Cincinnati, OH / Germany

Emery Oleochemicals’ oleochemical processing operations in Kuala Langat, Malaysia; Loxstedt, Germany; and Cincinnati, Ohio, produce natural-origin glycerin with a product positioning that emphasizes COSMOS-certified natural origin and bio-based credentials that meet clean-beauty and sustainable supply chain requirements from personal care and pharmaceutical customers seeking documented renewable carbon content in their glycerin supply. Emery is a joint venture between Sime Darby Plantation’s SD Guthrie subsidiary and PTT Global Chemical, combining access to Southeast Asian feedstocks with an industrial footprint in Europe and North America.

2025-2026 Update: Emery’s COSMOS-certified glycerin fits squarely into the personal care natural ingredients space, which is aligned with the clean-beauty regulatory trend in Europe and North America, where consumers and brands prefer independently certified natural-origin glycerin versus petroleum-derived or non-certified alternatives.

4. Godrej Industries | BSE: 500164 | Mumbai, India

Godrej Industries’ fatty chemicals branch has the largest integrated oleochemicals business in India, generating glycerin as a co-product of fatty acid, fatty alcohol and surfactant manufacture at its Valia, Gujarat site. India’s pharmaceutical industry is increasing rapidly along with the domestic demand for personal care ingredients, and Godrej’s glycerin business benefits from proximity to Indian pharma bulk-drug parks and personal care firms that would rather buy locally than import glycerin. Given India’s role as the world’s pharmacy by volume and the demand for USP/EP-grade glycerin by pharmaceutical formulators in the nation, domestic production of glycerin is strategically significant in India.

Update 2025-2026: Godrej’s position in the domestic Indian market serves India’s rapidly increasing pharmaceutical API production and personal care formulation sectors with a logistics and lead-time advantage over imported glycerin.

5. Procter & Gamble Chemicals | NYSE: PG | Cincinnati, OH, USA

P&G Chemicals' glycerin operations serve a dual commercial role: captive supply to Procter & Gamble's vast portfolio of personal care brands (Olay, Gillette, Ivory, Pantene) that consume glycerin as a key humectant and skin-conditioning ingredient, plus merchant sales of glycerin to external personal care and pharmaceutical formulators. P&G Chemicals produces 120,000+ tonnes per year of glycerin from its fatty chemical operations at Cincinnati, Ohio, and Bush, Louisiana, making it one of North America's largest glycerin producers with USP/EP pharmaceutical-grade certification.

2025–2026 Update: P&G's captive glycerin consumption provides stable production utilization that insulates P&G Chemicals' glycerin operations from spot market pricing cycles, while its merchant sales provide incremental revenue at commodity market pricing.

6. Cargill, Incorporated | Private | Minneapolis, MN, USA

Cargill's glycerin production comes primarily from its biodiesel (FAME) manufacturing operations in North America and Europe, where glycerol is co-produced as the transesterification byproduct of soybean, canola, and palm methyl ester production. With estimated FY2024 group revenue of approximately $160 billion and a biodiesel production capacity that makes Cargill one of North America's largest FAME producers under the US Renewable Fuel Standard, Cargill's glycerin supply is structurally linked to RFS mandate volumes rather than glycerin market demand specifically.

2025–2026 Update: The structural shift from FAME biodiesel to HVO renewable diesel represents a long-term supply risk for Cargill's glycerin co-production volumes, as HVO expansion displaces FAME capacity without generating glycerin co-product.

7. Archer-Daniels-Midland (ADM) | NYSE: ADM | Chicago, IL, USA

Glycerin is an important co-product of biodiesel manufacturing, and ADM markets glycerin from its US biodiesel operations, as well as other bio-based chemical intermediates, through its BioSolutions platform, which is part of the broader Agricultural Services & Oilseeds and Carbohydrate Solutions segments. ADM's BioSolutions platform increasingly focuses on developing higher-value glycerin derivative applications that capture more value from glycerin co-production than commodity glycerin merchant sales alone, with FY2024 group revenue of $85.5 billion (SEC filings, February 2025) down 8.9% year-on-year due to agricultural commodity price softness.

2025–2026 Update: ADM’s BioSolutions glycerin derivative development strategy is to commercialize glycerol as a feedstock for bio-based propylene glycol, 1,3-propanediol and other chemical intermediates, directly targeting the higher-value conversion of commodity glycerin into bio-based chemicals where margins are substantially better than commodity glycerin pricing.

8. BASF SE | FWB: BAS | Ludwigshafen, Germany

BASF's glycerin business operates across its Care Chemicals and Performance Chemicals segments, both supplying pharmaceutical-grade glycerin to European pharma customers and chemically converting glycerin into higher-value derivatives including glycerol carbonate (a bio-based solvent), propylene glycol (via hydrogenolysis), and as a component of BASF's broad personal care ingredients platform. With FY2024 group revenue of €65.3 billion, BASF's glycerin portfolio benefits from the company's deep European pharmaceutical and personal care customer relationships and its chemistry conversion capability that creates derivative products with higher margins than commodity glycerin.

2025–2026 Update: BASF's glycerin derivative conversion programs — including glycerol carbonate and the exploration of glycerin as a feedstock for epichlorohydrin via dichloropropanol — represent the kind of higher-value chemical conversion that large integrated chemical companies can pursue alongside commodity glycerin supply, capturing additional margin from the glycerin value chain that pure glycerin producers selling into the merchant market cannot access without equivalent chemical processing infrastructure.

9. IOI Loders Croklaan (IOI Group) | Bursa: IOI | Malaysia / Netherlands

IOI Loders Croklaan's glycerin business combines IOI Group's Malaysian palm oil refining operations with the Dutch Loders Croklaan heritage (formerly Unilever's specialty fats division) that provides an established European presence in premium specialty food and pharmaceutical glycerin markets. With IOI Group FY2024 revenue of approximately MYR 12.8 billion (~$2.7 billion USD), IOI Loders Croklaan's glycerin reaches European food manufacturers, pharmaceutical formulators, and personal care companies through its Dutch operational base with halal-certified supply chains serving Muslim-majority market requirements.

2025–2026 Update: IOI Loders Croklaan's halal-certified glycerin supply chain provides a commercially distinctive credential in the growing global halal food, pharmaceutical, and personal care market where glycerin's conventional derivation from animal-derived tallow can disqualify non-halal-certified glycerin from Muslim consumer-oriented product formulations.

10. Vantage Specialty Chemicals | Private (PE-backed) | Gurnee, IL, USA

Vantage Specialty Chemicals is one of North America's leading specialty oleochemical distributors and manufacturers, with its Rite-Sol® pharmaceutical-grade glycerin brand serving the North American pharmaceutical and personal care formulation markets with consistent-quality, USP/EP-documented glycerin supply supported by the technical service depth that larger commodity glycerin producers often do not provide to smaller customers. As a PE-backed private company, Vantage has built its North American specialty oleochemicals position through both organic growth and targeted acquisitions that have expanded its specialty ingredients portfolio.

2025–2026 Update: Vantage's Rite-Sol® brand's North American pharmaceutical customer base provides stable, recurring glycerin demand from pharmaceutical formulators who value supply reliability, quality documentation consistency, and technical service over marginal commodity pricing advantages from alternative glycerin sources.

SECTION 4 — M&A ACTIVITY TRACKER

SECTION 5 — R&D & INNOVATION SIGNALS

• Glycerin conversion to 1,3-propanediol (1,3-PDO) via microbial fermentation — producing a bio-based diol used in polytrimethylene terephthalate (PTT) fiber and cosmetic ingredients — is the highest-value glycerin valorization pathway currently scaling toward commercial production, with DuPont Tate & Lyle BioProducts' Bio-PDO® and several Asian fermentation producers competing for the growing sustainable textile and bio-cosmetics market.
• Glycerol carbonate production from glycerin and CO2 (or urea) is advancing toward commercial scale as a green solvent with exceptional biodegradability, low toxicity, and solvating properties for pharmaceutical, cosmetic, and coating applications, with BASF and several academic biorefinery consortia publishing process scale-up data that support commercial production cost projections below USD 2.00/kg by 2027.
• EUDR-compliant traceability technology for palm-derived glycerin — including satellite deforestation monitoring, GPS-georeferenced fresh fruit bunch origination, and blockchain-secured supply chain records — is becoming standard procurement infrastructure for Southeast Asian glycerin exporters targeting the European market, with Wilmar's NDPE (No Deforestation, No Peat, No Exploitation) monitoring system serving as the industry benchmark that smaller producers are progressively building toward.
• HVO-driven glycerin supply reduction, identified by IEA in its Biofuels 2024 report, is projected to remove 800,000–1,000,000 tonnes of annual glycerin co-production from the global supply base by 2030 as FAME biodiesel capacity stagnates while HVO expands, creating a structural supply tightening that rewards producers with diversified feedstock access (oleochemical-derived glycerin from palm refining rather than biodiesel) relative to FAME-dependent glycerin suppliers.
• Pharmaceutical glycerin demand growth from emerging markets — particularly India's PLI scheme-driven API manufacturing expansion and Indonesia's domestic pharmaceutical sector development under Made in Indonesia health product policies — is creating new regional pharmaceutical-grade glycerin procurement pools that domestic Southeast Asian glycerin producers (Wilmar, KLK, IOI) are positioned to serve with shorter supply chain lead times than European or US imports.
• Glycerin-based antifreeze and de-icing fluid applications, where bio-based glycerin provides biodegradable, lower-toxicity alternatives to conventional ethylene glycol and propylene glycol aircraft and runway de-icing agents, are growing in European aviation and rail applications as EU environmental regulations restrict ethylene-glycol-based de-icing discharge at airports near water bodies — creating a premium-priced environmental compliance application for pharmaceutical-grade glycerin at concentrations and volumes that represent meaningful incremental demand growth.